Difference between revisions of "Post-transplant lymphoproliferative disorder"
Jump to navigation
Jump to search
(create) |
m (→References) |
||
| Line 23: | Line 23: | ||
{{Reflist|1}} | {{Reflist|1}} | ||
[[Category: | [[Category:Haematopathology]] | ||
Revision as of 15:37, 3 March 2011
Post-transplant lymphoproliferative disorder, vbbreviated PTLD, is something afflicts people that had transplants (solid organ and bone marrow). It is essentially a type of B-cell lymphoma.
General
- Rare.
- B cell neoplasm associated with EBV.[1][2]
- Commonly in the GI tract as it gets the most immunosuppression; immunosuppressives are taken orally -- not cleaned by the liver prior to reaching the GI tract.
Microscopic
Features:
- Similar to large cell lymphomas:
- Large lymphoid cells with a diameter ~2x a resting lymphocyte.
- Nucleoli.
IHC
- B cell markers +ve
- EBER +ve -- diffuse.
See also
References
- ↑ URL: http://emedicine.medscape.com/article/431364-overview. Accessed on: 10 February 2011.
- ↑ Gottschalk S, Rooney CM, Heslop HE (2005). "Post-transplant lymphoproliferative disorders". Annu. Rev. Med. 56: 29–44. doi:10.1146/annurev.med.56.082103.104727. PMID 15660500.